New Results
The SARS-CoV-2 variant, Omicron, shows rapid replication in human primary nasal epithelial cultures and efficiently uses the endosomal route of entry
View ORCID ProfileThomas P. Peacock, View ORCID ProfileJonathan C. Brown, View ORCID ProfileJie Zhou, View ORCID ProfileNazia Thakur, Joseph Newman, View ORCID ProfileRuthiran Kugathasan, Ksenia Sukhova, View ORCID ProfileMyrsini Kaforou, View ORCID ProfileDalan Bailey, View ORCID ProfileWendy S. Barclay
doi: https://doi.org/10.1101/2021.12.31.474653
Thomas P. Peacock
1Department of Infectious Disease, Imperial College London, UK, W2 1PG
Jonathan C. Brown
1Department of Infectious Disease, Imperial College London, UK, W2 1PG
Jie Zhou
1Department of Infectious Disease, Imperial College London, UK, W2 1PG
Nazia Thakur
2The Pirbright Institute, Woking, Surrey, UK, GU24 0NF
Joseph Newman
2The Pirbright Institute, Woking, Surrey, UK, GU24 0NF
Ruthiran Kugathasan
1Department of Infectious Disease, Imperial College London, UK, W2 1PG
Ksenia Sukhova
1Department of Infectious Disease, Imperial College London, UK, W2 1PG
Myrsini Kaforou
1Department of Infectious Disease, Imperial College London, UK, W2 1PG
Dalan Bailey
2The Pirbright Institute, Woking, Surrey, UK, GU24 0NF
Wendy S. Barclay
1Department of Infectious Disease, Imperial College London, UK, W2 1PG

Article usage
Posted January 03, 2022.
The SARS-CoV-2 variant, Omicron, shows rapid replication in human primary nasal epithelial cultures and efficiently uses the endosomal route of entry
Thomas P. Peacock, Jonathan C. Brown, Jie Zhou, Nazia Thakur, Joseph Newman, Ruthiran Kugathasan, Ksenia Sukhova, Myrsini Kaforou, Dalan Bailey, Wendy S. Barclay
bioRxiv 2021.12.31.474653; doi: https://doi.org/10.1101/2021.12.31.474653
The SARS-CoV-2 variant, Omicron, shows rapid replication in human primary nasal epithelial cultures and efficiently uses the endosomal route of entry
Thomas P. Peacock, Jonathan C. Brown, Jie Zhou, Nazia Thakur, Joseph Newman, Ruthiran Kugathasan, Ksenia Sukhova, Myrsini Kaforou, Dalan Bailey, Wendy S. Barclay
bioRxiv 2021.12.31.474653; doi: https://doi.org/10.1101/2021.12.31.474653
Subject Area
Subject Areas
- Biochemistry (9096)
- Bioengineering (6742)
- Bioinformatics (23922)
- Biophysics (12069)
- Cancer Biology (9484)
- Cell Biology (13722)
- Clinical Trials (138)
- Developmental Biology (7614)
- Ecology (11646)
- Epidemiology (2066)
- Evolutionary Biology (15468)
- Genetics (10613)
- Genomics (14285)
- Immunology (9451)
- Microbiology (22756)
- Molecular Biology (9057)
- Neuroscience (48817)
- Paleontology (354)
- Pathology (1478)
- Pharmacology and Toxicology (2559)
- Physiology (3819)
- Plant Biology (8307)
- Synthetic Biology (2285)
- Systems Biology (6165)
- Zoology (1296)